Thalidomide-NH-CH2-COOH, 100mg

6-Bromo-5-(2-oxopropyl)benzo[d]oxazol-2(3H)-one, 97%, 250mg

2-Amino-quinoline-3-carboxylic acid amide, 95.0%, 25g

(2E)-1-(2,4-dimethylphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

N-(2,2,2-trifluoroethyl)pyridin-2-amine, 95.0%, 5g

4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-amino-, 1,1-dimethylethyl ester, 97%, 5g

4-BROMO-2-(TRIFLUOROMETHYL)-1H-INDOLE, 97.0%, 1g

1-(4-Chlorophenyl)biguanide hydrochloride, 97.0%, 250mg

D-Asparagine, N2-[(phenylmethoxy)carbonyl]-, 98%, 100g

5 mm NMR Economy Sample Tube w/ Cap, 7" L High-Throughput, 100x1ea

6-Chloro-2-methylnicotinic acid, 95.0%, 10g

1-(2-(2-Chloro-3-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)ethyl)-4-methylpiperazine, 98%, 50mg

Azetidine-1-carbothioamide, 98%, 1g